pISSN 3022-6783
eISSN 3022-7712

View

Article View

Korean J Transplant 2022; 36(3): 187-196

Published online September 30, 2022

https://doi.org/10.4285/kjt.22.0029

© The Korean Society for Transplantation

Cardiac evaluation for end-stage kidney disease patients on the transplant waitlist: a single-center cohort study

Swati Vijayan1 , Quan Yao Ho2,3 , Choong Hou Koh4 , Ian Tatt Liew2,3 , Sobhana Thangaraju2,3 , Ningyan Wong4 , Yann Shan Keh4 , Zi Hui Sharel Ong2,3 , Jia Qin Tan2,3 , Khung Keong Yeo4 , Terrance Siang Jin Chua4 , Terence Kee2,3

1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
2Department of Renal Medicine, Singapore General Hospital, Singapore
3SingHealth Duke-NUS Transplant Centre, Singapore
4Department of Cardiology, National Heart Centre, Singapore

Correspondence to: Quan Yao Ho
Department of Renal Medicine, Singapore General Hospital, Outram Rd, Singapore 169608, Singapore
Tel: +65-6222-3322
Fax: +65-6222-2038
E-mail: ho.quan.yao@singhealth.com.sg

Received: June 23, 2022; Revised: August 20, 2022; Accepted: August 29, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: Cardiac evaluation before deceased donor kidney transplant (DDKT) remains a matter of debate. Data on Asian countries and countries with prolonged waiting times are lacking. This study aimed to assess the outcomes of patients referred for DDKT after a cardiac evaluation at an Asian tertiary transplant center.
Methods: This single-center retrospective review analyzed patients who were referred for waitlist placement and underwent cardiac stress testing between January 2009 and December 2015. Patients with cardiac symptoms were excluded. The primary outcome was three-point major adverse cardiovascular events (MACE), a composite of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death.
Results: Of 468 patients referred for DDKT, 198 who underwent cardiac stress testing (myocardial perfusion studies in 159 patients and stress echocardiography in 39 patients) were analyzed. MACE occurred in 20.7% of the patients over a median follow-up of 4.6 years. Cardiac stress tests were positive for ischemia in 19.7% of the patients. Coronary angiography was performed in 63 patients, including 29 patients with diabetic kidney disease and negative cardiac stress tests. Significant coronary artery disease (CAD) was detected in 27 patients (42.8%), of whom 18 underwent revascularization. MACE was associated with significant CAD on coronary angiography in the multivariable analysis. Cardiac stress test results were not associated with MACE. Amongst diabetic patients who had negative cardiac stress tests, 37.9% had significant CAD on coronary angiography.
Conclusions: The cardiovascular disease burden is significant amongst DDKT waitlist candidates. Pretransplant cardiac screening may identify patients with significant CAD at higher risk of MACE.

Keywords: Kidney transplantation, Cardiovascular diseases, Echocardiography, Stress, Myocardial perfusion imaging, Coronary angiography

HIGHLIGHTS
  • A cohort of 198 patients on the kidney transplant waitlist was followed for 4.6 years.

  • Major adverse cardiovascular events developed in 20.7% of the patients during follow-up.

  • Significant coronary artery disease on cardiac angiography was correlated with major adverse cardiovascular events.